Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ASXC | Common Stock | Award | $0 | +13.8K | $0.00 | 13.8K | Jul 1, 2021 | Direct | F1, F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ASXC | Stock Option | Award | $0 | +10K | $0.00 | 10K | Jun 30, 2021 | Common Stock | 10K | $3.17 | Direct | F4, F5 |
Id | Content |
---|---|
F1 | Represents restricted stock units ("RSUs"). Each RSU represents the right to receive one share of the Registrant's common stock. |
F2 | Forfeiture restrictions will lapse on the RSUs on the first anniversary of the date of grant, provided that if the date of the 2022 annual meeting of stockholders is earlier, the restrictions will lapse on the date of the annual meeting. |
F3 | The Reporting Person has assigned shares issued from prior grants of restricted stock units to SV Health Investors in accordance with its operating agreement and is expected to transfer the shares underlying this reported award upon vesting. |
F4 | Represents an equity award issued under the Registrant's Amended and Restated Incentive Compensation Plan in lieu of an annual cash retainer, paid quarterly in arrears for the quarter ended June 30, 2021. |
F5 | The award is fully exercisable six months after the grant date, subject to earlier acceleration as approved by the Board of Directors. |